GDF15 and metabolic dysfunction-associated steatotic liver disease: Moreover, as shown in Figure 1, we found that the median circulating levels of GDF15 were 395.6 pg/mL in the control group and 640.0 pg/mL in the MASLD group, with a statistically significant difference between the groups (p < 0.0001).